All lobbying filings

Stanton Park Group

Stanton Park Group filed a Q4 report for McKesson Corpation and Its Affiliate US Oncology (Formerly US Oncology) on January 20, 2026, reporting $60,000 in lobbying income.

Lobbying for McKesson Corpation and Its Affiliate US Oncology (Formerly US Oncology)

As filed: STANTON PARK GROUP for MCKESSON CORPATION AND ITS AFFILIATE US ONCOLOGY (FORMERLY US ONCOLOGY).

All filings by Stanton Park Group · Everything McKesson Corpation and Its Affiliate US Oncology (Formerly US Oncology) has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

Texas

Official filing document

Lobbyists on this filing 4

BRYAN WILLIAM WELLS

Previously held: Policy Advisor, Senator Pat Roberts
AISLING MCDONOUGH

Previously held: Chief of Staff, Rep. Anna Eshoo; Senior Health Advisor, Rep. Anna Eshoo; Policy Coordinator, Energy & Commerce Committee; Legislative Assistant, Sen. Brian Schatz
JAMES DERDERIAN

Previously held: Chief of Staff, House Commerce Committee; Legislative Advisor to Rep. Tom Bliley
VALERIE HENRY

Previously held: Legislative Director, Rep. Greg Walden; Legislative Assistant to Sen. John Warner and Sen. Mike Crapo

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Medicare, oncology, radiation and imaging reimbursement issues; medicare physician payments; Oncology payment disparities in Medicare.; Health information technology; application of the sequester to cancer drug reimbursement; prompt pay discount; safety and security of the prescription drug supply chain.

Health Issues

H.R.2484, Seniors Access to Critical Medications Act of 2025

Bills named in this filing 1

H.R. 2484
Seniors’ Access to Critical Medications Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.